Dr Kai-Keen Shiu qualified at Guys and St Thomas’ Medical School. He trained in medical oncology in London including St George’s Hospital, the Royal Free Hospital and University College London Hospital. He completed his PhD in integrative genomic profiling of cancer at the Institute of Cancer Research and the Royal Marsden Hospital. He also attained a research fellowship at the MRC Clinical Trials Unit at UCL as part of the FOCUS4 Trial Management Group.
Dr Shiu is a Consultant in the Gastrointestinal Oncology Unit at UCLH and is the Clinical Lead for the Acute Oncology Service as well as the Cancer of Unknown Primary Service. He is a Chief Investigator or Principal Investigator for a number of national and international gastrointestinal immuno-oncology trials including JavelinGastric100, POLEM, KEYNOTE 177, 811 and 859. He is the UK Chief Investigator for CUPISCO, a 1st line Phase 2 randomised molecular guided therapy trial for patients with CUP.
Dr Shiu is Chair of the NCRI MUO/CUP Workstream. He is a collaborator in the PEACE (Posthumous tissuE donAtion in CancEr) study, and a member of the Gastrointestinal Oncology and CUP subgroups at UCLH/UCL Cancer Institute/Francis Crick Institute. He is the Principal Investigator of the UCL/UCLH Gastrointestinal Cancer Translational Research Biobank. He teaches widely in the UK and abroad, and is a Honorary Associate Professor at the UCL Cancer Institute.